Concentrations de cadmium, plomb, mercure et césium 137 dans les tissus de caribous (Rangifer tarandus) abattus dans le territoire du Nouveau-Québec

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal

Le traitement du trouble délirant et ses aspects cognitifs

Cet article fait état de la phénoménologie cognitive du trouble délirant (TD) et examine les modèles cognitifs actuels. Des études de cas ont mis à jour des résultats forts prometteurs concernant l'utilisation de la thérapie cognitivo-comportementale (TCC) pour traiter le TD, même si cette dernière n'en est qu'à ses débuts dans ce domaine. Bien que les étapes de la TCC pour traiter le TD soient très similaires à ceux de la TCC pour les autres troubles psychotiques, son approche comporte des différences considérables. Toutefois, il est primordial de combiner plusieurs stratégies afin de pouvoir modifier les inférences propres au TD. L'évaluation clinique des délires ainsi que l'application de la TCC comme traitement seront illustrées par deux études de cas comportant des diagnostics de TD à thème prédominant de persécution. Les cas ont requis des périodes de temps différentes lors des diverses étapes de la TCC, suggérant l'importance de poursuivre la TCC au besoin.Cognitive aspects and treatment of delusional disorders This article reviews the cognitive phenomenology of delusional disorders (DD) and examines the current cognitive models. Some case studies have shown considerable promise concerning the utilisation of cognitive behavioral therapy (CBT) for the treatment of DD, even if this approach is in its infancy. Although the stages of CBT to treat DD are very similar to that of other psychotic disorders, there are also considerable differences. However, it is essential to combine several strategies in order to modify inferences specific to DD. The clinical evaluation of delusions as well as the application of CBT as a treatment is illustrated in two cases with a diagnosis of DD with persecutory subtype. The cases required different time periods for different stages of CBT and highlight the importance of tailoring CBT according to need.El tratamiento del trastorno delirante y sus aspectos cognitivos Este artículo tiene en cuenta la fenomenología cognitiva del trastorno delirante (TD) y examina los modelos congnitivos actuales. Investigaciones recientes han puesto al día resultados prometedores referente a la utilisación de la terapia cognitiva-comportamiento (TCC) para tratar el TD, aunque esta última esté empesando en este campo. Aunque las etapas de la TCC para tratar el TD sean similares a los de la TCC para otros trastornos psicóticos, su aproximación comporte diferencias considerables. Sin embargo es primordial combinar varias estrategias para modifiar las inferencias propias al TD. La evaluación clínica de los delirios asi que la aplicación de la TCC como tratamiento son ilustrados por dos estudios de casos incluyendo diagnósticos de TD con tema predominante de persecusión. Los casos han requerido periodas de tiempo diferentes durante las varias etapas de la TCC, sugeriendo la importancia de seguir con la TCC si es preciso

Chitosan as an antioxidant alternative to sulphites in oenology: EPR investigation of inhibitory mechanisms

The efficacy against oxidative degradation in model and sulphite-free white wines of two commercial, insoluble chitosans (one being approved for winemaking) were investigated by electron paramagnetic resonance (EPR). Both compounds at various doses significantly inhibited the formation of \u3b1-(4-pyridyl-1-oxide)-N-t-butylnitrone (4-POBN)-1-hydroxyethyl adducts under normal wine storage conditions. Pre-incubation with 2 g/L chitosan followed by filtration had a better effect than adding 50 mg/L sulphur dioxide to the experimental Chardonnay wine on the release of 4-POBN adducts after 6 days of incubation with 100 \u3bcM iron(II). In a relevant photooxidative system acetaldehyde formation was significantly reduced after 6 days of incubation. Parallel EPR tests were performed to assess the importance of metal chelation (iron and copper) versus direct scavenging of hydroxyl radicals on the effect of chitosan. The present data support the potentiality of using biocompatible chitosan as a healthier complement and/or alternative to sulphur dioxide against white wine oxidative spoilage

Treating delusional disorder : a comparison of cognitive-behavioural therapy and attention placebo control

Objective: Cognitive-behavioural therapy (CBT) has proved effective in treating delusions, both in schizophrenia and delusional disorder (DD). Clinical trials of DD have mostly compared CBT with either treatment as usual, no treatment, or a wait-list control. This current study aimed to assess patients with DD who received CBT, compared with an attention placebo control (APC) group. Method: Twenty-four individuals with DD were randomly allocated into either CBT or APC groups for a 24-week treatment period. Patients were diagnosed on the basis of structured clinical interviews for mental disorders and the Maudsley Assessment of Delusion Schedule (MADS). Results: Completers in both groups (n = 11 for CBT; n = 6 for APC) showed clinical improvement on the MADS dimensions of Strength of Conviction, Insight, Preoccupation, Systematization, Affect Relating to Belief, Belief Maintenance Factors, and Idiosyncrasy of Belief. Conclusion: When compared with APC, CBT produced more impact on the MADS dimensions for Affect Relating to Belief, Strength of Conviction, and Positive Actions on Beliefs

Early emergence of CD19-negative human antibody secreting cells at the plasmablast to plasma cell transition

Long-lived human plasma cells (PCs) play central roles in immunity and autoimmunity and are enriched amongst the subpopulation of CD19-negative human PCs. However, whether human CD19-negative PCs are necessarily ″aged″ cells that have gradually lost CD19 expression is not known. Assessing peripheral blood samples at steady state and during the acute response to influenza vaccination in healthy donors we identify the presence of phenotypic CD19-negative plasmablasts, the proliferative precursor state to mature PCs, and demonstrate by ELISpot that these are antibody-secreting cells (ASCs). During the acute response to influenza vaccination CD19-positive, CD19-low and CD19-negative ASCs secrete vaccine-specific antibody and show linked IGHV repertoires. To address precursor/product relationships we employ in vitro models which mimic both T-dependent and T-independent differentiation finding that the CD19-negative state can be established at the plasmablast to PC transition, that CD19-negative PCs increase as a percentage of surviving PCs in vitro, and that CD19-negative and CD19-positive PCs can be maintained independently. These data provide proof-of-principle for the view that newly generated ASCs can acquire a mature PC phenotype accompanied by loss of CD19 expression at an early stage of differentiation and that ″aging″ is not an obligate requirement for a CD19-negative state to be established

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.

Although targeted therapies often elicit profound initial patient responses, these effects are transient due to residual disease leading to acquired resistance. How tumors transition between drug responsiveness, tolerance and resistance, especially in the absence of preexisting subclones, remains unclear. In epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma cells, we demonstrate that residual disease and acquired resistance in response to EGFR inhibitors requires Aurora kinase A (AURKA) activity. Nongenetic resistance through the activation of AURKA by its coactivator TPX2 emerges in response to chronic EGFR inhibition where it mitigates drug-induced apoptosis. Aurora kinase inhibitors suppress this adaptive survival program, increasing the magnitude and duration of EGFR inhibitor response in preclinical models. Treatment-induced activation of AURKA is associated with resistance to EGFR inhibitors in vitro, in vivo and in most individuals with EGFR-mutant lung adenocarcinoma. These findings delineate a molecular path whereby drug resistance emerges from drug-tolerant cells and unveils a synthetic lethal strategy for enhancing responses to EGFR inhibitors by suppressing AURKA-driven residual disease and acquired resistance

A Comprehensive Framework for Saturation Theorem Proving

A crucial operation of saturation theorem provers is deletion of subsumed formulas. Designers of proof calculi, however, usually discuss this only informally, and the rare formal expositions tend to be clumsy. This is because the equivalence of dynamic and static refutational completeness holds only for derivations where all deleted formulas are redundant, but the standard notion of redundancy is too weak: A clause C does not make an instance Cσ redundant. We present a framework for formal refutational completeness proofs of abstract provers that implement saturation calculi, such as ordered resolution and superposition. The framework modularly extends redundancy criteria derived via a familiar ground-to-nonground lifting. It allows us to extend redundancy criteria so that they cover subsumption, and also to model entire prover architectures so that the static refutational completeness of a calculus immediately implies the dynamic refutational completeness of a prover implementing the calculus within, for instance, an Otter or DISCOUNT loop. Our framework is mechanized in Isabelle/HOL

A Comprehensive Framework for Saturation Theorem Proving

We present a framework for formal refutational completeness proofs of abstract provers that implement saturation calculi, such as ordered resolution or superposition. The framework relies on modular extensions of lifted redundancy criteria. It allows us to extend redundancy criteria so that they cover subsumption, and also to model entire prover architectures in such a way that the static refutational completeness of a calculus immediately implies the dynamic refutational completeness of a prover implementing the calculus, for instance within an Otter orloop. Our framework is mechanized in Isabelle/